Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Osteosarcoma-derived extracellular vesicles induce a tumor-like phenotype in normal recipient cells.

Urciuoli E, Giorda E, Scarsella M, Petrini S, Peruzzi B.

J Cell Physiol. 2018 Aug;233(8):6158-6172. doi: 10.1002/jcp.26464. Epub 2018 Mar 7.

PMID:
29323709
2.

Two-site evaluation of the diagnostic performance of the Sysmex XN Body Fluid (BF) module for cell count and differential in Cerebrospinal Fluid.

Buoro S, Peruzzi B, Fanelli A, Seghezzi M, Manenti B, Lorubbio M, Biagioli T, Nannini S, Ottomano C, Lippi G.

Int J Lab Hematol. 2018 Feb;40(1):26-33. doi: 10.1111/ijlh.12723. Epub 2017 Sep 3.

PMID:
28866874
3.

Src nuclear localization and its prognostic relevance in human osteosarcoma.

Urciuoli E, Coletta I, Rizzuto E, De Vito R, Petrini S, D'Oria V, Pezzullo M, Milano GM, Cozza R, Locatelli F, Peruzzi B.

J Cell Physiol. 2018 Feb;233(2):1658-1670. doi: 10.1002/jcp.26079. Epub 2017 Aug 17.

PMID:
28671269
4.

CEBPA-double-mutated acute myeloid leukemia displays a unique phenotypic profile: a reliable screening method and insight into biological features.

Mannelli F, Ponziani V, Bencini S, Bonetti MI, Benelli M, Cutini I, Gianfaldoni G, Scappini B, Pancani F, Piccini M, Rondelli T, Caporale R, Gelli AM, Peruzzi B, Chiarini M, Borlenghi E, Spinelli O, Giupponi D, Zanghì P, Bassan R, Rambaldi A, Rossi G, Bosi A.

Haematologica. 2017 Mar;102(3):529-540. doi: 10.3324/haematol.2016.151910. Epub 2016 Nov 10.

5.

Dysregulation of sphingosine 1 phosphate receptor-1 (S1P1) signaling and regulatory lymphocyte-dependent immunosuppression in a model of post-fingolimod MS rebound.

Cavone L, Felici R, Lapucci A, Buonvicino D, Pratesi S, Muzzi M, Hakiki B, Maggi L, Peruzzi B, Caporale R, Annunziato F, Amato MP, Chiarugi A.

Brain Behav Immun. 2015 Nov;50:78-86. doi: 10.1016/j.bbi.2015.06.019. Epub 2015 Jun 27.

PMID:
26130058
6.

Multilineage dysplasia as assessed by immunophenotype has no impact on clinical-biological features and outcome of NPM1-mutated acute myeloid leukemia.

Mannelli F, Ponziani V, Bonetti MI, Bencini S, Cutini I, Gianfaldoni G, Scappini B, Pancani F, Rondelli T, Benelli M, Caporale R, Grazia Gelli AM, Peruzzi B, Longo G, Bosi A.

Exp Hematol. 2015 Oct;43(10):869-879.e22. doi: 10.1016/j.exphem.2015.06.003. Epub 2015 Jun 20.

PMID:
26101160
7.

Long-term suppression of EAE relapses by pharmacological impairment of epitope spreading.

Cavone L, Peruzzi B, Caporale R, Chiarugi A.

Br J Pharmacol. 2014 Mar;171(6):1501-9. doi: 10.1111/bph.12525.

8.

Diagnosis of a T-lineage acute lymphoblastic leukemia through digitalized cell analysis of the pleural effusion.

Peruzzi B, Cutini I, Gelli AM, Rondelli T, Statello M, Bencini S, Mannelli F, Caporale R, Bosi A, Fanelli A.

Int Med Case Rep J. 2013 Nov 1;6:77-80. doi: 10.2147/IMCRJ.S49278. eCollection 2013.

9.

Polymorphism of the complement receptor 1 gene correlates with the hematologic response to eculizumab in patients with paroxysmal nocturnal hemoglobinuria.

Rondelli T, Risitano AM, Peffault de Latour R, Sica M, Peruzzi B, Ricci P, Barcellini W, Iori AP, Boschetti C, Valle V, Frémeaux-Bacchi V, De Angioletti M, Socie G, Luzzatto L, Notaro R.

Haematologica. 2014 Feb;99(2):262-6. doi: 10.3324/haematol.2013.090001. Epub 2013 Sep 13.

10.

Proline/arginine-rich end leucine-rich repeat protein N-terminus is a novel osteoclast antagonist that counteracts bone loss.

Rucci N, Capulli M, Ventura L, Angelucci A, Peruzzi B, Tillgren V, Muraca M, Heinegård D, Teti A.

J Bone Miner Res. 2013 Sep;28(9):1912-24. doi: 10.1002/jbmr.1951.

11.

The frequency of granulocytes with spontaneous somatic mutations: a wide distribution in a normal human population.

Rondelli T, Berardi M, Peruzzi B, Boni L, Caporale R, Dolara P, Notaro R, Luzzatto L.

PLoS One. 2013;8(1):e54046. doi: 10.1371/journal.pone.0054046. Epub 2013 Jan 14.

12.

A systematic analysis of bone marrow cells by flow cytometry defines a specific phenotypic profile beyond GPI deficiency in paroxysmal nocturnal hemoglobinuria.

Mannelli F, Bencini S, Peruzzi B, Cutini I, Sanna A, Benelli M, Magi A, Gianfaldoni G, Rotunno G, Carrai V, Gelli AM, Valle V, Santini V, Notaro R, Luzzatto L, Bosi A.

Cytometry B Clin Cytom. 2013 Mar;84(2):71-81. doi: 10.1002/cyto.b.21064. Epub 2012 Dec 26.

13.

Spleen endothelial cells from patients with myelofibrosis harbor the JAK2V617F mutation.

Rosti V, Villani L, Riboni R, Poletto V, Bonetti E, Tozzi L, Bergamaschi G, Catarsi P, Dallera E, Novara F, Massa M, Campanelli R, Fois G, Peruzzi B, Lucioni M, Guglielmelli P, Pancrazzi A, Fiandrino G, Zuffardi O, Magrini U, Paulli M, Vannucchi AM, Barosi G; Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative (AGIMM) investigators.

Blood. 2013 Jan 10;121(2):360-8. doi: 10.1182/blood-2012-01-404889. Epub 2012 Nov 5.

14.

Targeted disruption of heparan sulfate interaction with hepatocyte and vascular endothelial growth factors blocks normal and oncogenic signaling.

Cecchi F, Pajalunga D, Fowler CA, Uren A, Rabe DC, Peruzzi B, Macdonald NJ, Blackman DK, Stahl SJ, Byrd RA, Bottaro DP.

Cancer Cell. 2012 Aug 14;22(2):250-62. doi: 10.1016/j.ccr.2012.06.029.

15.

Overall evaluation of an immunological latex agglutination system for fecal occult blood testing in the colorectal cancer screening program of Florence.

Rubeca T, Peruzzi B, Confortini M, Rapi S.

Int J Biol Markers. 2012 Oct 8;27(3):e195-202. doi: 10.5301/JBM.2012.9343.

PMID:
22865297
16.

c-Src and IL-6 inhibit osteoblast differentiation and integrate IGFBP5 signalling.

Peruzzi B, Cappariello A, Del Fattore A, Rucci N, De Benedetti F, Teti A.

Nat Commun. 2012 Jan 17;3:630. doi: 10.1038/ncomms1651.

PMID:
22252554
17.

Easy genotyping of complement C3 'slow' and 'fast' allotypes by tetra-primer amplification refractory mutation system PCR.

Peruzzi B, Serra M, Pescucci C, Sica M, Lastraioli S, Rondelli T, Pedemonte S, Risitano AM, De Angioletti M, Piccioli P, Notaro R.

Mol Cell Probes. 2010 Dec;24(6):401-2. doi: 10.1016/j.mcp.2010.07.002. Epub 2010 Jul 22.

PMID:
20655380
18.

Selective inhibition of carbonic anhydrase IX decreases cell proliferation and induces ceramide-mediated apoptosis in human cancer cells.

Cianchi F, Vinci MC, Supuran CT, Peruzzi B, De Giuli P, Fasolis G, Perigli G, Pastorekova S, Papucci L, Pini A, Masini E, Puccetti L.

J Pharmacol Exp Ther. 2010 Sep 1;334(3):710-9. doi: 10.1124/jpet.110.167270. Epub 2010 Jun 2.

PMID:
20519553
19.

Committed osteoclast precursors colonize the bone and improve the phenotype of a mouse model of autosomal recessive osteopetrosis.

Cappariello A, Berardi AC, Peruzzi B, Del Fattore A, Ugazio A, Bottazzo GF, Teti A.

J Bone Miner Res. 2010 Jan;25(1):106-13. doi: 10.1359/jbmr.090715.

20.

The use of PIG-A as a sentinel gene for the study of the somatic mutation rate and of mutagenic agents in vivo.

Peruzzi B, Araten DJ, Notaro R, Luzzatto L.

Mutat Res. 2010 Jul-Sep;705(1):3-10. doi: 10.1016/j.mrrev.2009.12.004. Epub 2009 Dec 24. Review.

PMID:
20034593
21.

Selectivity and mechanism of action of a growth factor receptor-bound protein 2 SRC homology 2 domain binding antagonist.

Giubellino A, Shi ZD, Jenkins LM, Worthy KM, Bindu LK, Athauda G, Peruzzi B, Fisher RJ, Appella E, Burke TR, Bottaro DP.

J Med Chem. 2008 Dec 11;51(23):7459-68. doi: 10.1021/jm800523u.

22.

A new heterozygous mutation (R714C) of the osteopetrosis gene, pleckstrin homolog domain containing family M (with run domain) member 1 (PLEKHM1), impairs vesicular acidification and increases TRACP secretion in osteoclasts.

Del Fattore A, Fornari R, Van Wesenbeeck L, de Freitas F, Timmermans JP, Peruzzi B, Cappariello A, Rucci N, Spera G, Helfrich MH, Van Hul W, Migliaccio S, Teti A.

J Bone Miner Res. 2008 Mar;23(3):380-91.

23.

Involvement of PLEKHM1 in osteoclastic vesicular transport and osteopetrosis in incisors absent rats and humans.

Van Wesenbeeck L, Odgren PR, Coxon FP, Frattini A, Moens P, Perdu B, MacKay CA, Van Hul E, Timmermans JP, Vanhoenacker F, Jacobs R, Peruzzi B, Teti A, Helfrich MH, Rogers MJ, Villa A, Van Hul W.

J Clin Invest. 2007 Apr;117(4):919-30.

24.

Beta-catenin signaling: linking renal cell carcinoma and polycystic kidney disease.

Peruzzi B, Bottaro DP.

Cell Cycle. 2006 Dec;5(24):2839-41. Epub 2006 Dec 6.

PMID:
17218789
25.

Modulation of human estrogen receptor alpha F promoter by a protein kinase C/c-Src-dependent mechanism in osteoblast-like cells.

Longo M, Peruzzi B, Fortunati D, De Luca V, Denger S, Caselli G, Migliaccio S, Teti A.

J Mol Endocrinol. 2006 Dec;37(3):489-502.

PMID:
17170089
26.

Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system.

De Benedetti F, Rucci N, Del Fattore A, Peruzzi B, Paro R, Longo M, Vivarelli M, Muratori F, Berni S, Ballanti P, Ferrari S, Teti A.

Arthritis Rheum. 2006 Nov;54(11):3551-63.

27.

The von Hippel-Lindau tumor suppressor gene product represses oncogenic beta-catenin signaling in renal carcinoma cells.

Peruzzi B, Athauda G, Bottaro DP.

Proc Natl Acad Sci U S A. 2006 Sep 26;103(39):14531-6. Epub 2006 Sep 18.

28.

Targeting the c-Met signaling pathway in cancer.

Peruzzi B, Bottaro DP.

Clin Cancer Res. 2006 Jun 15;12(12):3657-60. Review.

29.

Molecular targeting of growth factor receptor-bound 2 (Grb2) as an anti-cancer strategy.

Dharmawardana PG, Peruzzi B, Giubellino A, Burke TR Jr, Bottaro DP.

Anticancer Drugs. 2006 Jan;17(1):13-20. Review.

PMID:
16317285
30.

Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment.

Del Fattore A, Peruzzi B, Rucci N, Recchia I, Cappariello A, Longo M, Fortunati D, Ballanti P, Iacobini M, Luciani M, Devito R, Pinto R, Caniglia M, Lanino E, Messina C, Cesaro S, Letizia C, Bianchini G, Fryssira H, Grabowski P, Shaw N, Bishop N, Hughes D, Kapur RP, Datta HK, Taranta A, Fornari R, Migliaccio S, Teti A.

J Med Genet. 2006 Apr;43(4):315-25. Epub 2005 Aug 23.

31.

Does the determination of the Bb vitamin D receptor genotype identify psoriasis vulgaris patients responsive to topical tacalcitol?

Giomi B, Ruggiero M, Fabbri P, Gulisano M, Peruzzi B, Caproni M, Pacini S.

J Dermatol Sci. 2005 Mar;37(3):180-1. Epub 2005 Jan 6. No abstract available.

PMID:
15734288
32.

Proteolysis of human plasma reveals the presence of complexes formed by endogenous heparin and peptides that stimulate angiogenesis.

Pacini S, Ruggiero M, Cecchi F, Peruzzi B, Vannucchi S.

Oncol Res. 2004;14(10):501-11.

PMID:
15559764
33.

0.2 T magnetic field inhibits angiogenesis in chick embryo chorioallantoic membrane.

Ruggiero M, Bottaro DP, Liguri G, Gulisano M, Peruzzi B, Pacini S.

Bioelectromagnetics. 2004 Jul;25(5):390-6.

PMID:
15197764
34.

Vitamin D receptor gene polymorphism is not associated with psoriasis in the Italian Caucasian population.

Ruggiero M, Gulisano M, Peruzzi B, Giomi B, Caproni M, Fabbri P, Pacini S.

J Dermatol Sci. 2004 Jun;35(1):68-70. No abstract available.

PMID:
15194150
35.

Effects of 0.2 T static magnetic field on human skin fibroblasts.

Pacini S, Gulisano M, Peruzzi B, Sgambati E, Gheri G, Gheri Bryk S, Vannucchi S, Polli G, Ruggiero M.

Cancer Detect Prev. 2003;27(5):327-32.

PMID:
14585318
36.

Association between atmospheric ozone levels and damage to human nasal mucosa in Florence, Italy.

Pacini S, Giovannelli L, Gulisano M, Peruzzi B, Polli G, Boddi V, Ruggiero M, Bozzo C, Stomeo F, Fenu G, Pezzatini S, Pitozzi V, Dolara P.

Environ Mol Mutagen. 2003;42(3):127-35.

PMID:
14556220
37.

[Ships over the whole world may receive health care via radio from Gothenburg].

Peruzzi B.

Lakartidningen. 1995 Aug 9;92(32-33):2873-4. Swedish. No abstract available.

PMID:
7643696

Supplemental Content

Loading ...
Support Center